What's up, what's down, how's the market doing, know it all right here! ARN: We recommend adding 40-50 words of introductory content related to Infobyte, covering the keywords "infobyte, stock market news" (3-4 occurrences). What's up, what's down, how's the market doing, know it all right here! We recommend adding 40-50 words of introductory content related to Infobyte, covering the keywords "infobyte, stock market news"
ARN: We recommend to add content explaining Overview of the news and other sections. We recommend to add content explaining Overview of the news and other sections.
Jindal Steel: The company has completed the 6mtpa expansion at Angul, taking its crude steel capacity in Angul to 12mtpa and its total capacity. This expansion positions Jindal Steel as the fourth-largest steel producer in India. Supported by the incremental capacity and improving domestic demand, MOFSL expects the steelmaker to witness a 17 per cent CAGR in volume. Coupled with steady NSR growth and an increasing value-added portfolio, revenue is projected to witness a 21 per cent CAGR over FY26-28. The company has posted strong earnings in Q4FY26, and on coal gasification, this company will get benefit from coal gasification. Positive
JSW Steel: The company reported consolidated Crude Steel production for April’26 at 21.18 Lakh tonnes. Production growth, excluding BF3 production from last year’s base, was about 10%, driven by the full ramp-up of JVML operations. The capacity utilisation of its India operations for the month stood at 83%. Neutral.
Titan: Customs duties on imports of gold, silver, platinum, and jewelry components have been increased by the government from 5% to 10%. Due to an increase in manufacturing costs, jewelry supplies will be under pressure.
Dr Reddy’s (-ve): Total revenue from operations of the generic drugmaker was lower at Rs.7,546.4 crore (₹8,528.4 crore), according to the results prepared as per Indian Accounting Standards. Result included adverse impact of a Shelf Stock Adjustment (SSA) related to lenalidomide (generic of cancer drug Revlimid) of Rs.453 crore, impairment of CAR-T assets and Eftilagimod Alfa of a total of Rs.227.7 crore, provisions related to VAT liability of Rs.114.1 crore during the quarter. For the full year FY26, consolidated net profit of Dr. Reddy’s declined to Rs. 4,157.6 crore (Rs.5,725.2 crore). Total revenue from operations rose to Rs.33,700 crore (Rs.32,643.9 crore).
Sri Lotus Developers : The company delivered a strong FY26 performance with pre-sales rising 137% YoY to Rs. 1,157 crore, revenue increasing 40% YoY to Rs. 769 crore, and PAT at Rs. 243 crore with healthy margins. The company remained net debt-free with gross cash of Rs. 849 crore and added nine new projects with cumulative GDV of around Rs. 8,500–9,000 crore during the year. Project Celestia in Versova saw strong traction with bookings of Rs. 155 crore within seven days of launch. For FY27, management has guided for pre-sales of Rs. 1,800–2,000 crore supported by six planned launches and continued strong demand in the luxury housing segment.
Stock Update: Thermax Q4FY26 Results – Recovering order inflows- Maintain Hold
Stock update: Radico Khaitan Q4FY26 (Consolidated) result update – Strong Q4; outlook positive
Lemon Tree Hotels (LTHL): The company has announced the launch of its latest property, Keys Select by Lemon Tree Hotels, Amritsar. The opening strengthens LTHL’s North India footprint with brand’s third hotel in Punjab. The hotel features 50 well-appointed rooms, Keys Café, a boardroom and a fitness center. Positive